SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-011195
Filing Date
2020-06-15
Accepted
2020-06-15 17:13:58
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3658
  Complete submission text file 0001493152-20-011195.txt   5807
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1050 30TH STREET NW SUITE 107 WASHINGTON DC 20007
Business Address 1050 30TH STREET NW SUITE 107 WASHINGTON DC 20007 (732) 410-9810
Avant Diagnostics, Inc (Reporting) CIK: 0001451929 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 0930
Type: 3 | Act: 34 | File No.: 000-52218 | Film No.: 20964176
SIC: 8071 Services-Medical Laboratories